Schizophrenia - Risperidone Long-Acting Injection Extends Time To Relapse Compared To Oral Quetiapine

A new study, presented for the first time at an international psychiatric meeting, examined the time to relapse in patients with schizophrenia treated with risperidone long-acting injection (RLAI) or oral quetiapine. The data show that the mean time free from relapse for patients treated with RLAI was statistically longer than those treated with quetiapine (607 days RLAI versus 533 days with quetiapine, p

More: continued here

Filed under: Mental Health on May 15th, 2008